Lipoprotein (a): current evidence for a physiologic role and the effects of nutraceutical strategies

HO Santos, R Kones, U Rumana, CP Earnest… - Clinical Therapeutics, 2019 - Elsevier
Purpose Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …
被引用次数：41 相关文章

Lipoprotein (a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies.

HO Santos, R Kones, U Rumana, CP Earnest… - Clinical …, 2019 - europepmc.org
Purpose Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …

Lipoprotein (a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies

HO Santos, R Kones, U Rumana… - Clinical …, 2019 - clinicaltherapeutics.com
Purpose Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …

Lipoprotein (a): current evidence for a physiologic role and the effects of nutraceutical strategies.

HO Santos, R Kones, U Rumana, CP Earnest… - 2019 - cabidigitallibrary.org
Purpose: Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …

Lipoprotein (a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies

HO Santos, R Kones, U Rumana… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Cardiovascular (CV) diseases account for most worldwide mortality, and a higher
level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk factor. However …